A. Ruhle

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma

D. Busch, J. Ruland, E. Khatamzas, 2021, HemaSphere.

Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID‐19 from influenza pneumonia

P. Boor, R. Zimmer, M. Rudelius, 2020, Journal of Thrombosis and Haemostasis.

Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020

H. Blum, J. Mayerle, E. Khatamzas, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection

W. Hammerschmidt, O. Keppler, M. Albanese, 2020, bioRxiv.

Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses

K. Conzelmann, V. Hornung, D. N. Levy, 2021, Nature methods.

Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses

L. Kaderali, V. Hornung, J. Mayerle, 2021, Cell Reports.

Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses

K. Conzelmann, V. Hornung, D. N. Levy, 2021, Nature Methods.